SAN DIEGO, CA / ACCESSWIRE / January 9, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all ...

LOS ANGELES, CA / ACCESSWIRE / January 8, 2025 / The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class ...

Department now forecasts that the company will earn $1.07 per share for the quarter, up from their prior estimate of $1.06. The consensus estimate for AstraZeneca’s current full-year earnings is ...

Whereas the latter derives most of its revenue from a few diabetes or obesity drugs, AstraZeneca has a large and diversified pipeline of medicines. The company's products span the field of ...

CAMBRIDGE, England, November 12, 2024--AstraZeneca today announces $3.5 billion of capital investment in the United States focused on expanding the Company’s research and manufacturing footprint ...

The Hungarian citizen’s case will progress to a final hearing against AstraZeneca at a later date ... In 2022, the company introduced a policy which said all employees should work for three ...

U.K.-based pharmaceutical giant AstraZeneca (NASDAQ: AZN) is making news, but not in a good way. Its operations in China were recently rocked when Leon Wang, the company's president in the country ...

We recently compiled a list of the 10 Best FTSE Dividend Stocks To Buy Now. In this article, we are going to take a look at ...

LONDON, Dec 13 (Reuters Breakingviews) - Pascal Soriot is stuck in a Chinese limbo. In recent months, the CEO of $205 billion drug giant AstraZeneca (AZN.L), opens new tab has seen his China boss ...

3 Stocks to DOUBLE This Year The 10 Best Stocks to Own in 2023 7 Stocks to Buy and Hold Forever Shares of AstraZeneca stock opened at £104.68 ($132.12) on Wednesday. The company has a debt-to ...

AstraZeneca PLC (LSE/STO/NASDAQ: LON:AZN), a leading biopharmaceutical company with a market capitalization of $206.73 billion, today announced the appointment of Rene Haas and Birgit Conix as Non ...

These developments come at a crucial time for AstraZeneca's Chinese operations, though the company maintains its commitment to this key market. The pharmaceutical giant's swift response demonstrates ...